- Home
- CORT vs INGR Comparison
CORT vs INGR Comparison
Compare CORT & INGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- INGR
- Stock Information
- Founded
- CORT 1998
- INGR 1906
- Country
- CORT United States
- INGR United States
- Employees
- CORT N/A
- INGR N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- INGR Packaged Foods
- Sector
- CORT Health Care
- INGR Consumer Staples
- Exchange
- CORT Nasdaq
- INGR Nasdaq
- Market Cap
- CORT 7.6B
- INGR 8.6B
- IPO Year
- CORT N/A
- INGR 1997
- Fundamental
- Price
- CORT $79.80
- INGR $124.04
- Analyst Decision
- CORT Strong Buy
- INGR Hold
- Analyst Count
- CORT 4
- INGR 5
- Target Price
- CORT $139.00
- INGR $151.40
- AVG Volume (30 Days)
- CORT 720.7K
- INGR 468.1K
- Earning Date
- CORT 10-29-2025
- INGR 11-04-2025
- Dividend Yield
- CORT N/A
- INGR 2.58%
- EPS Growth
- CORT N/A
- INGR 4.50
- EPS
- CORT 1.11
- INGR 10.23
- Revenue
- CORT $716,080,000.00
- INGR $7,316,000,000.00
- Revenue This Year
- CORT $30.62
- INGR $2.02
- Revenue Next Year
- CORT $37.68
- INGR $2.45
- P/E Ratio
- CORT $71.25
- INGR $12.14
- Revenue Growth
- CORT 25.71
- INGR N/A
- 52 Week Low
- CORT $40.15
- INGR $120.51
- 52 Week High
- CORT $117.33
- INGR $155.44
- Technical
- Relative Strength Index (RSI)
- CORT 68.64
- INGR 37.53
- Support Level
- CORT $69.03
- INGR $123.36
- Resistance Level
- CORT $74.79
- INGR $127.50
- Average True Range (ATR)
- CORT 2.93
- INGR 1.90
- MACD
- CORT 0.73
- INGR -0.27
- Stochastic Oscillator
- CORT 98.97
- INGR 9.48
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About INGR Ingredion Incorporated
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.